CorRen Medical, Inc.
CorRen is preventing limb loss by making Peripheral Artery Disease testing universal and accessible
- Stage Prototype Ready
- Industry Medical Devices and Equipment
- Location Minneapolis, MN, USA
- Currency USD
- Founded December 2022
- Employees 3
- Incorporation Type C-corp
- Website correnmedical.com
Company Summary
CorRen is tackling limb loss by making Peripheral Artery Disease (PAD) testing universal and accessible. Our multi-element ultrasound technology provides a user-friendly, reimbursable solution for simplified PAD detection. Currently, 80% of eligible patients do not receive annual PAD testing due to the limitations of existing alternatives. CorRen will solve this with a PAD test that is more accurate, faster, easier to use, and reimbursed by CMS.
Team
-
President & CEOMike is a seasoned executive with over 30 years of experience leading multiple startup medical device companies and serving as a board member for several private and publicly traded life science companies. Mike served as President & CEO of SpineTech 2000-2005, Anulex Technologies 2005-2010 and Osprey Medical 2011-2023. Mike received his Bachelor of Business Administration, Business Management from The University of Texas at Austin.
-
David LernerChief Technology OfficerDavid has over 20 years experience in medical technology design, development, quality systems and team leadership. He has held executive product, technology, and organizational development leadership roles in several firms in the Med Tech sector.
-
John ErbChairman and Co-FounderJohn has over 45 years of experience in the medical device industry. He has served as chief executive officer, and board member of both public and private medical device firms.
Advisors
-
Nancy Ness, CFOUnconfirmed
Dr. Anand Prasad, Medical AdvisorUnconfirmed -
Suneel Arora, IP CounselUnconfirmed -
Rachel Armstrong, Coding Strategic AdvisorUnconfirmed
Previous Investors
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.